help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, L.-W.
Right arrow Articles by Lau, K.-H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, L.-W.
Right arrow Articles by Lau, K.-H. W.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 4 1126-1135
Copyright © 1997 by The Endocrine Society


Endocrinological Oncology

Fluoride at Mitogenic Doses Induces a Sustained Activation of p44mapk, but Not p42mapk, in Human TE85 Osteosarcoma Cells1

Li-Wha Wu, Hyun Koo Yoon, David J. Baylink, Lee M. Graves and K.-H. William Lau

Departments of Medicine and Biochemistry, Loma Linda University, and the Mineral Metabolism Unit, Jerry L. Pettis Memorial Veterans Administration Medical Center, Loma Linda, California 92357; and the Department of Pharmacology, University of North Carolina (L.M.G.), Chapel Hill, North Carolina 27514

Address all correspondence and requests for reprints to: Dr. K.-H. William Lau, Mineral Metabolism (151), Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton Street, Loma Linda, California 92357. E-mail: LAUB{at}LLVAMC.VA.GOV

Fluoride, at micromolar concentrations, stimulates bone cell proliferation in vitro. In this study, we sought to test whether fluoride at mitogenic doses increases the tyrosyl phosphorylation level and specific activity of a mitogen-activated protein kinase (MAPK) in human TE85 osteosarcoma cells. Analysis by immunoprecipitation with antiphosphotyrosine antibody followed by Western analysis using an anti-pan extracellular signal-regulated kinase antibody revealed that fluoride at the optimal mitogenic dose (i.e. 100 µmol/L) induced a time-dependent increase in the steady state tyrosyl phosphorylation level of p44mapk, but not p42mapk, with the maximal increase (4- to 13-fold) after 1–3 h fluoride treatment. The effect was sustained in that a 9-fold increase was seen after 12 h of the fluoride treatment. The sustained nature of the effect is consistent with an inhibition of dephosphorylation rather than a direct stimulation of phosphorylation. The fluoride effect on the tyrosyl phosphorylation level of p44mapk was dose dependent, with the optimal dose being 100 µmol/L fluoride. The mitogenic dose of fluoride also increased the specific activity and the in-gel kinase activity of p44mapk, but not that of p42mapk, in a time-dependent manner similar to the effect on the p44mapk tyrosyl phosphorylation level. Fluoride at the same micromolar doses did not increase cell proliferation, tyrosyl phosphorylation, or specific activity of any MAPK in human skin foreskin fibroblasts, which are fluoride-nonresponsive cells. Consistent with the interpretation that the effect of fluoride on the steady state tyrosyl phosphorylation level of p44mapk is a consequence of an inhibition of a phosphotyrosyl phosphatase (PTP), mitogenic doses of orthovanadate, a bone cell mitogen and a PTP inhibitor, also increased the steady state tyrosyl phosphorylation level of p44mapk, but not p42mapk, in a time-dependent sustained manner similar to that observed with fluoride. Together, these findings support the concept that inhibition of a PTP activity in bone cells could lead to an activation of MAPK activity.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. V. Bogatcheva, P. Wang, A. A. Birukova, A. D. Verin, and J. G. N. Garcia
Mechanism of fluoride-induced MAP kinase activation in pulmonary artery endothelial cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1139 - L1145.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. V. Thrane, M. Refsnes, G. H. Thoresen, M. Lag, and P. E. Schwarze
Fluoride-Induced Apoptosis in Epithelial Lung Cells Involves Activation of MAP Kinases p38 and Possibly JNK
Toxicol. Sci., May 1, 2001; 61(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
M Refsnes, R Becher, M Lag, T Skuland, and P E Schwarze
Fluoride-induced interleukin-6 and interleukin-8 synthesis in human epithelial lung cells
Human and Experimental Toxicology, November 1, 1999; 18(11): 645 - 652.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
W. B. Bowler, C. J. Dixon, C. Halleux, R. Maier, G. Bilbe, W. D. Fraser, J. A. Gallagher, and R. A. Hipskind
Signaling in Human Osteoblasts by Extracellular Nucleotides. THEIR WEAK INDUCTION OF THE c-fos PROTO-ONCOGENE VIA Ca2+ MOBILIZATION IS STRONGLY POTENTIATED BY A PARATHYROID HORMONE/cAMP-DEPENDENT PROTEIN KINASE PATHWAY INDEPENDENTLY OF MITOGEN-ACTIVATED PROTEIN KINASE
J. Biol. Chem., May 14, 1999; 274(20): 14315 - 14324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. A. Hulley, F. Gordon, and F. S. Hough
Inhibition of Mitogen-Activated Protein Kinase Activity and Proliferation of an Early Osteoblast Cell Line (MBA 15.4) by Dexamethasone: Role of Protein Phosphatases
Endocrinology, May 1, 1998; 139(5): 2423 - 2431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society